help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Published ahead of print on April 22, 2005, doi:10.1164/rccm.200409-1181PP
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200409-1181PPv1
172/2/149    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wenzel, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wenzel, S.
American Journal of Respiratory and Critical Care Medicine Vol 172. pp. 149-160, (2005)
© 2005 American Thoracic Society
doi: 10.1164/rccm.200409-1181PP

Pulmonary Perspective

Severe Asthma in Adults

Sally Wenzel

National Jewish Medical and Research Center, Denver, Colorado

Correspondence and requests for reprints should be addressed to Sally Wenzel, M.D., National Jewish Medical and Research Center, 1400 Jackson Street, Denver, CO 80206. E-mail: wenzels{at}njc.org

ABSTRACT

Severe asthma remains poorly understood and frustrating to care for, partly because it is a heterogeneous disease. Patients with severe asthma disproportionately consume health care resources related to asthma. Severe asthma may develop over time, or shortly after onset of the disease. The genetic and environmental elements that may be most important in the development of severe disease are poorly understood, but likely include both allergic and nonallergic elements. Physiologically, these patients often have air trapping, airway collapsibility, and a high degree of methacholine hyperresponsiveness. Specific phenotypes of severe asthma are only beginning to be defined. However, describing severe asthma by age at onset (early- vs. late-onset) appears to describe two phenotypes that differ at immunologic, physiologic, epidemiologic, and pathologic levels. In particular, early-onset severe asthma is a more allergic-associated disease than late-onset severe asthma. In addition, patients with severe asthma can be defined on the basis of presence and type of inflammation. Severe asthma with persistent eosinophilia (of either early or late onset) is more symptomatic and has more near-fatal events. However, at least 50% of patients with severe asthma have very little identifiable inflammation. Thus, "steroid resistance" may occur at numerous levels, not all of which are caused by a lack of effect of steroids on inflammation. Treatment remains problematic, with corticosteroids remaining the most effective therapy. However, 5-lipoxygenase inhibitors, anti-IgE, and immunomodulatory drugs are also likely to have a place in treatment. Improving therapy in this disease will require a better understanding of the phenotypes involved.

Key Words: asthma • inflammation • physiology • phenotypes • remodeling • treatment




This article has been cited by other articles:


Home page
 Eur Respir JHome page
M. Duong, A. M. Wilson, L. Jayaram, M. Dolovich, and F. Hargreave
The effect of inhaled lidocaine-hydrofluoroalkane 134a in prednisone-dependent eosinophilic bronchitis
Eur. Respir. J., October 1, 2008; 32(4): 1119 - 1122.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
I. H. van Veen, A. ten Brinke, P. J. Sterk, J. K. Sont, S. A. Gauw, K. F. Rabe, and E. H. Bel
Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma
Eur. Respir. J., August 1, 2008; 32(2): 344 - 349.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
T. Suzuki, H. Arakawa, T. Mizuno, K. Muramatsu, H. Tadaki, T. Takizawa, H. Mochizuki, K. Tokuyama, S. Matsukura, and A. Morikawa
Differential Regulation of Eotaxin Expression by Dexamethasone in Normal Human Lung Fibroblasts
Am. J. Respir. Cell Mol. Biol., June 1, 2008; 38(6): 707 - 714.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A. Michils, S. Baldassarre, and A. Van Muylem
Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients
Eur. Respir. J., March 1, 2008; 31(3): 539 - 546.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
R. L. Sorkness, E. R. Bleecker, W. W. Busse, W. J. Calhoun, M. Castro, K. F. Chung, D. Curran-Everett, S. C. Erzurum, B. M. Gaston, E. Israel, et al.
Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation
J Appl Physiol, February 1, 2008; 104(2): 394 - 403.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
E. D. Bateman, S. S. Hurd, P. J. Barnes, J. Bousquet, J. M. Drazen, M. FitzGerald, P. Gibson, K. Ohta, P. O'Byrne, S. E. Pedersen, et al.
Global strategy for asthma management and prevention: GINA executive summary
Eur. Respir. J., January 1, 2008; 31(1): 143 - 178.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
I. D. Pavord, G. Cox, N. C. Thomson, A. S. Rubin, P. A. Corris, R. M. Niven, K. F. Chung, M. Laviolette, and the RISA Trial Study Group
Safety and Efficacy of Bronchial Thermoplasty in Symptomatic, Severe Asthma
Am. J. Respir. Crit. Care Med., December 15, 2007; 176(12): 1185 - 1191.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. H. Lee, T. Haselkorn, L. Borish, L. Rasouliyan, B. E. Chipps, and S. E. Wenzel
Risk Factors Associated With Persistent Airflow Limitation in Severe or Difficult-to-Treat Asthma: Insights From the TENOR Study
Chest, December 1, 2007; 132(6): 1882 - 1889.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A. L. James and S. Wenzel
Clinical relevance of airway remodelling in airway diseases
Eur. Respir. J., July 1, 2007; 30(1): 134 - 155.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Sturrock, T. P. Huecksteadt, K. Norman, K. Sanders, T. M. Murphy, P. Chitano, K. Wilson, J. R. Hoidal, and T. P. Kennedy
Nox4 mediates TGF-beta1-induced retinoblastoma protein phosphorylation, proliferation, and hypertrophy in human airway smooth muscle cells
Am J Physiol Lung Cell Mol Physiol, June 1, 2007; 292(6): L1543 - L1555.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A. Papi, P. L. Paggiaro, G. Nicolini, A. M. Vignola, L. M. Fabbri, and on behalf of the Inhaled Combination Asthma Treatm
Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma
Eur. Respir. J., April 1, 2007; 29(4): 682 - 689.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. L. Sorkness, K. M. Herricks, R. J. Szakaly, R. F. Lemanske Jr, and L. A. Rosenthal
Altered allergen-induced eosinophil trafficking and physiological dysfunction in airways with preexisting virus-induced injury
Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L85 - L91.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
J. S. Siegle, N. Hansbro, C. Herbert, M. Yang, P. S. Foster, and R. K. Kumar
Airway Hyperreactivity in Exacerbation of Chronic Asthma Is Independent of Eosinophilic Inflammation
Am. J. Respir. Cell Mol. Biol., November 1, 2006; 35(5): 565 - 570.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. E. Wenzel and R. Covar
Update in asthma 2005.
Am. J. Respir. Crit. Care Med., April 1, 2006; 173(7): 698 - 706.
[Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
M. E. Strek
Difficult asthma.
Proceedings of the ATS, January 1, 2006; 3(1): 116 - 123.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2005 American Thoracic Society 		  ATS State of the Art Course 2008